Ilya M Rachman Immix Biopharma, Inc. (IMMX) insider trading activity

Ilya M Rachman is CEO and Chairman of Immix Biopharma, Inc.. Currently has a direct ownership of 1.14 Million shares of IMMX, which is worth approximately $4.8 Million. The most recent transaction as insider was on Sep 17, 2025, when has been sold 2,500 shares (Common Stock) at a price of $2.02 per share, resulting in proceeds of $5,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.14M

0.22% 3M change

0.41% 12M change

Total Value Held $4.8 Million

Ilya M Rachman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 17 2025	BUY Open market or private purchase	$5,050 $2.02 p/Share	2,500 Added 0.22%	1,140,937 Common Stock
Jun 18 2025	BUY Open market or private purchase	$4,987 $2.29 p/Share	2,178 Added 0.19%	1,138,437 Common Stock
Jun 07 2024	BUY Open market or private purchase	$5,538 $2.13 p/Share	2,600 Added 0.23%	1,136,259 Common Stock
Jun 04 2024	BUY Open market or private purchase	$5,973 $1.81 p/Share	3,300 Added 0.29%	1,133,659 Common Stock
May 20 2024	BUY Grant, award, or other acquisition	-	218,359 Added 16.19%	1,130,359 Common Stock
May 14 2024	BUY Open market or private purchase	$9,675 $2.25 p/Share	4,300 Added 0.47%	912,000 Common Stock
Nov 14 2022	BUY Open market or private purchase	$5,148 $0.99 p/Share	5,200 Added 0.57%	907,700 Common Stock
Dec 20 2021	BUY Open market or private purchase	$12,500 $5.0 p/Share	2,500 Added 0.28%	902,500 Common Stock

IMR

Ilya M Rachman

CEO and Chairman

Los Angeles, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMMX shares.

Notify only if

Value

Insider Trading

Get notified when an Immix Biopharma, Inc. insider buys or sells IMMX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Immix Biopharma, Inc.

Track Activities on IMMX

Account